PlainRecalls
FDA Devices Moderate Class II Terminated

ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine.

Reported: March 13, 2019 Initiated: January 2, 2019 #Z-0971-2019

Product Description

ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine.

Reason for Recall

Abbott internal testing has identified that the Magnesium urine application demonstrates depressed urine result recovery. All samples >0.5mEq/L fail the linearity acceptance criteria for the bias specification and demonstrate depressed recovery of up to 37%. The specific cause of the negative bias/depressed results is currently under investigation.

Details

Recalling Firm
Abbott Laboratories, Inc
Units Affected
24,995 units
Distribution
Worldwide Distribution: US (nationwide) and to countries of: CHINA, THAILAND, GUATEMALA, and EL SALVADOR.
Location
Irving, TX

Frequently Asked Questions

What product was recalled?
ARCHITECT MAGNESIUM, (a) REF 7D70-21, (b) 7D70-31 The Magnesium assay is used for the quantitation of magnesium in human serum, plasma, or urine.. Recalled by Abbott Laboratories, Inc. Units affected: 24,995 units.
Why was this product recalled?
Abbott internal testing has identified that the Magnesium urine application demonstrates depressed urine result recovery. All samples >0.5mEq/L fail the linearity acceptance criteria for the bias specification and demonstrate depressed recovery of up to 37%. The specific cause of the negative bias/depressed results is currently under investigation.
Which agency issued this recall?
This recall was issued by the FDA Devices on March 13, 2019. Severity: Moderate. Recall number: Z-0971-2019.